[1]李新萍,张萍,李晓玉.螺内酯对特发性醛固酮增多症患者胰岛β细胞功能的影响[J].国际内分泌代谢杂志,2014,(06):379-382.[doi:10.3760/cma.j.issn.1673-4157.2014.06.005]
　Li Xinping,Zhang Ping,Li Xiaoyu..Effects of spironolactone on islet β cell function in patients with idiopathic hyperaldosteronism[J].International Journal of Endocrinology and Metabolism,2014,(06):379-382.[doi:10.3760/cma.j.issn.1673-4157.2014.06.005]
点击复制

螺内酯对特发性醛固酮增多症患者胰岛β细胞功能的影响()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2014年06期
页码:
379-382
栏目:
论著
出版日期:
2014-12-20

文章信息/Info

Title:
Effects of spironolactone on islet β cell function in patients with idiopathic hyperaldosteronism
作者:
李新萍; 张萍; 李晓玉
100035 北京积水潭医院,北京大学第四临床医学院干部保健科内分泌专业组
Author(s):
Li Xinping; Zhang Ping; Li Xiaoyu.
Department of Geriatrics-Endocrine Group,Beijing Jishuitan Hospital,The 4th Medical College of Peking University,Beijing 100035,China
关键词:
特发性醛固酮增多症;  胰岛β细胞;  胰岛素抵抗;  肾上腺皮质增生
Keywords:
Idiopathic hyperaldosteronism;  Islet β cell;  Insulin resistance;  Hyperplasia of the adrenal cortex
DOI:
10.3760/cma.j.issn.1673-4157.2014.06.005
摘要:
目的 观察特发性醛固酮增多症(IHA)患者服用螺内酯前、后胰岛β细胞功能的变化。方法 选择北京积水潭医院2000年至2014年期间诊治的80例IHA患者为研究对象。按是否服用螺内酯分为螺内酯组(52例)及非螺内酯组(28例),平均随访28个月,比较两组患者在不同治疗前、后稳态模型评估-胰岛素抵抗指数(HOMA-IR)的变化,并分析其相关因素。结果 IHA患者经螺内酯治疗后,血钾由(3.13±0.69)mmol/L升高至(4.25±0.60)mmol/L(P=0.00); 醛固酮肾素比值(ARR)由64(16,189)下降至12(7,27,P<0.01); 应用60～80 mg螺内酯治疗的患者其β细胞功能优于应用螺内酯20 mg治疗者。治疗后HOMA-IR的变化和立位醛固酮有正相关的趋势(r=0.020,P=0.050)。结论 IHA患者的胰岛素抵抗与高醛固酮血症有关,中等剂量的螺内酯治疗对改善胰岛素抵抗有效。
Abstract:
Objective To investigate the changes of islet β cell function in patients with idiopathic hyperaldosteronism(IHA)after taking spironolactone. Methods Eighty patients with IHA from 2000 to 2014 were investigated. They were divided into spironolactone group(52 cases)and non spironolactone group(28 cases)according to whether taking spironolactone or not. After following-up for 28 months, the homeostasis model assessment-insulin resistance index(HOMA-IR)and related factors were compared and analyzed before and after treatment. Results After treated by spironolactone, the potassemia of IHA patients was improved from(3.13±0.69)mmol/L to(4.25±0.60)mmol/L(P=0.000), and aldosterone-to-renin ratio was decreased from 64(16,189)to 12(7,27)(P<0.05).Patients treated with 60-80 mg spironolactone had a better β cell function compared with those treated with 20 mg spironolactone.The change of HOMA-IR after treated by spironolactone was positively correlated with orthostatic aldosterone(r=0.020,P=0.050). Conclusion In patients with IHA, insulin resistance is related to hyperaldosteronism, medium dose of spironolactone is efficient in stabilizing insulin resistance.

参考文献/References:

[1] Kaplan NM.Primary aldosteronism: an update on screening, diagnosis and treatment[J].J Hypertens,2008,26(8):1708-1709; author reply 1709-1711.
[2] Sindelka G,Widimsky J,Haas T,et al.Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment[J].Exp Clin Endocrinol Diabetes,2000,108(1):21-25.
[3] Widimsky J,Sindelka G,Haas T,et al.Impaired insulin action in primary hyperaldosteronism[J].Physiol Res,2000,49(2):241-244.
[4] Garg R,Hurwitz S,Williams GH,et al.Aldosterone production and insulin resistance in healthy adults[J].J Clin Endocrinol Metab,2010,95(4):1986-1990.
[5] Li N,Wang M,Wang H,et al.Prevalence of primary aldosteronism in hypertensive subjects with hyperglycemia[J].Clin Exp Hypertens,2013,35(3):175-182.
[6] Henquin JC.Triggering and amplifying pathways of regulation of insulin secretion by glucose[J].Diabetes,2000,49(11):1751-1760.
[7] Kumagai E,Adachi H,Jacobs DR,et al.Plasma aldosterone levels and development of insulin resistance: prospective study in a general population[J].Hypertension,2011,58(6):1043-1048
[8] Selvaraj J,Muthusamy T,Srinivasan C,et al.Impact of excess aldosterone on glucose homeostasis in adult male rat[J].Clin Chim Acta,2009,407(1-2):51-57.
[9] Hitomi H,Kiyomoto H,Nishiyama A,et al.Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells[J].Hypertension,2007,50(4):750-755.
[10] Wada T,Ohshima S,Fujisawa E,et al.Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate(IRS)1 and IRS2 via a reactive Oxygen species-mediated pathway in 3T3-L1 adipocytes[J].Endocrinology,2009,150(4):1662-1669.
[11] Luther J M,Luo P,Kreger MT,et al.Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets[J].Diabetologia,2011,54(8):2152-2163.
[12] Corry DB,Tuck ML.The effect of aldosterone on glucose metabolism[J].Curr Hypertens Rep,2003,5(2):106-109.
[13] Catena C,Lapenna R,Baroselli S,et al.Insulin sensitivity in patients with primary aldosteronism: a follow-up study[J].J Clin Endocrinol Metab,2006,91(9):3457-3463.
[14] Giacchetti G,Ronconi V,Turchi F,et al.Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study[J].J Hypertens,2007,25(1):177-186.
[15] Funder J W,Carey RM,Fardella C,et al.Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline[J].J Clin Endocrinol Metab,2008,93(9):3266-3281.

相似文献/References:

[1]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
　Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(06):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[2]任寒,王恺,丁元林,等.miR-375与2型糖尿病[J].国际内分泌代谢杂志,2014,(05):330.[doi:10.3760/cma.j.issn.1673-4157.2014.05.012]
　Ren Han*,Wang Kai,Ding Yuanlin,et al.Relationship between miR-375 and type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2014,(06):330.[doi:10.3760/cma.j.issn.1673-4157.2014.05.012]
[3]Ming Liu,Jinhong Sun,Jingqiu Cui,等.胰岛素基因突变: 从遗传学和β细胞 生物学到临床疾病[J].国际内分泌代谢杂志,2016,36(02):128.[doi:10.3760/cma.j.issn.1673-4157.2016.02.013]
[4]陈煜,曹萌,刘超.自噬在2型糖尿病中的作用[J].国际内分泌代谢杂志,2016,36(05):346.[doi:10.3760/cma.j.issn.1673-4157.2016.05.16]
　Chen Yu,Cao Meng,Liu Chao.Role of autophagy in type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(06):346.[doi:10.3760/cma.j.issn.1673-4157.2016.05.16]
[5]薛静静,王彦.替米沙坦保护胰岛β细胞功能的研究进展[J].国际内分泌代谢杂志,2017,37(01):42.[doi:10.3760/cma.j.issn.1673-4157.2017.01.12]
　Xue Jingjing,Wang Yan..Research progress in protecting islet β cell function of telmisartan[J].International Journal of Endocrinology and Metabolism,2017,37(06):42.[doi:10.3760/cma.j.issn.1673-4157.2017.01.12]
[6]朱海娇,王幸,陈树春,等.SERCA2b与胰岛β细胞功能[J].国际内分泌代谢杂志,2017,37(06):411.
　Zhu Haijiao,Wang Xing,Chen Shuchun,et al.SERCA2b and the function of islet β cells[J].International Journal of Endocrinology and Metabolism,2017,37(06):411.
[7]薛君力 代喆 曾姣娥 徐焱成.RIP140在姜黄素抑制MIN6细胞凋亡中的 作用机制[J].国际内分泌代谢杂志,2018,38(03):154.[doi:10.3760/cma.j.issn.1673-4157.2018.03.003]
　Xue Junli*,Dai Zhe,Zeng Jiao'e,et al.Role of RIP140 in the inhibition of curcumin on apoptosis in MIN6 cells[J].International Journal of Endocrinology and Metabolism,2018,38(06):154.[doi:10.3760/cma.j.issn.1673-4157.2018.03.003]
[8]袁叶青 包玉倩.外泌体参与糖尿病发生的机制研究[J].国际内分泌代谢杂志,2018,38(02):102.[doi:10.3760/cma.j.issn.1673-4157.2018.02.008]
　Yuan Yeqing,Bao Yuqian.Researches on the mechanism of exosomes in diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(06):102.[doi:10.3760/cma.j.issn.1673-4157.2018.02.008]
[9]钱瑶 曾姣娥 薛君力.白细胞介素-22与2型糖尿病及其并发症[J].国际内分泌代谢杂志,2019,39(05):337.[doi:10.3760/cma.j.issn.1673-4157.2019.05.012]
　Qian Yao,Zeng Jiao'e,Xue Junli.Interleukin-22, type 2 diabetes mellitus and its complications[J].International Journal of Endocrinology and Metabolism,2019,39(06):337.[doi:10.3760/cma.j.issn.1673-4157.2019.05.012]
[10]邓莉莉,邝瑞军,彭艳辉.HDAC抑制剂CG200745促进STZ诱导糖尿病大鼠胰岛β细胞损伤后的再生修复[J].国际内分泌代谢杂志,2021,41(04):332.[doi:10.3760/cma.j.cn121383-20200618-06050]
　Deng Lili,Kuang Ruijun,Peng Yanhui..HDAC inhibitor CG200745 promotes regeneration and repair of islet β-cells in STZ-induced diabetic rats[J].International Journal of Endocrinology and Metabolism,2021,41(06):332.[doi:10.3760/cma.j.cn121383-20200618-06050]

更新日期/Last Update: 2014-12-20